AU1684999A - Chymase inhibitors - Google Patents
Chymase inhibitorsInfo
- Publication number
- AU1684999A AU1684999A AU16849/99A AU1684999A AU1684999A AU 1684999 A AU1684999 A AU 1684999A AU 16849/99 A AU16849/99 A AU 16849/99A AU 1684999 A AU1684999 A AU 1684999A AU 1684999 A AU1684999 A AU 1684999A
- Authority
- AU
- Australia
- Prior art keywords
- chymase inhibitors
- chymase
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9-353572 | 1997-12-22 | ||
JP35357297 | 1997-12-22 | ||
PCT/JP1998/005786 WO1999032459A1 (en) | 1997-12-22 | 1998-12-21 | Chymase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1684999A true AU1684999A (en) | 1999-07-12 |
Family
ID=18431753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU16849/99A Abandoned AU1684999A (en) | 1997-12-22 | 1998-12-21 | Chymase inhibitors |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1684999A (en) |
WO (1) | WO1999032459A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6972296B2 (en) | 1999-05-07 | 2005-12-06 | Encysive Pharmaceuticals Inc. | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
AU7954900A (en) * | 1999-10-25 | 2001-05-08 | Senju Pharmaceutical Co., Ltd. | Tension-relieving agents for ciliary muscle |
AU2001280590A1 (en) * | 2000-07-18 | 2002-01-30 | Neurogen Corporation | 5-substituted 2-aryl-4-pyrimidinones |
WO2002051815A1 (en) * | 2000-12-26 | 2002-07-04 | Ono Pharmaceutical Co., Ltd. | Pyrimidine derivatives and process for preparing the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100400639B1 (en) * | 1995-04-27 | 2003-12-31 | 미쯔비시 웰 파마 가부시키가이샤 | Heterocyclic amide compounds and their medicinal uses |
JPH107661A (en) * | 1996-06-20 | 1998-01-13 | Green Cross Corp:The | New heterocyclic amide compound and its medicinal use |
-
1998
- 1998-12-21 AU AU16849/99A patent/AU1684999A/en not_active Abandoned
- 1998-12-21 WO PCT/JP1998/005786 patent/WO1999032459A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1999032459A1 (en) | 1999-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6477498A (en) | Scale inhibitors | |
ZA98376B (en) | Sulfamide-metalloprotease inhibitors | |
GB2321641B (en) | Sulfamide-metalloprotease inhibitors | |
AU3140695A (en) | 1h-indole-1-functional spla2 inhibitors | |
EP0820453A4 (en) | Thrombin inhibitors | |
EP0835109A4 (en) | Pyridinone-thrombin inhibitors | |
EP0969840A4 (en) | Thrombin inhibitors | |
AU4787596A (en) | Thrombin inhibitors | |
AU1301697A (en) | Tyrosin-derivate as alpha-v-integrin inhibitors | |
AU3102397A (en) | Metalloprotease inhibitors | |
AU7497596A (en) | Thrombin inhibitors | |
EP0971891A4 (en) | Thrombin inhibitors | |
AU7139598A (en) | Protease inhibitors | |
AU2723099A (en) | Tryptase inhibitors | |
AU8997498A (en) | Tryptase inhibitor | |
AU6422798A (en) | Stabilized urease inhibitor | |
AU1013997A (en) | Amylase inhibitors | |
AU9300298A (en) | Protease inhibitors | |
AU3042697A (en) | Thrombin inhibitors | |
AUPP076797A0 (en) | Phospholipase inhibitor | |
AU2373600A (en) | Novel spla2 inhibitors | |
AU6049796A (en) | Lysyloxidase inhibitors | |
AU4618197A (en) | Thrombin inhibitors | |
AU2908197A (en) | Thrombin inhibitors | |
AU1684999A (en) | Chymase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |